Dr. Jenkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-255-3125
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1983 - 1987
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1983
Certifications & Licensure
- MN State Medical License 1984 - 2025
- American Board of Medical Genetics and Genomics Clinical Cytogenetics
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA.Cecile Riviere-Cazaux, Xiaoxi Dong, Wei Mo, Rahul Kumar, Chao Dai
Clinical Cancer Research. 2025-03-03 - Switching Drivers: Epigenetic Rewiring to Genetic Progression in Glioma.Kristen L Drucker, Robert B Jenkins, Daniel Schramek
Cancer Research. 2025-03-03 - Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers.Hussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, Jesse S Voss, Beth A Pitel
The Journal of Molecular Diagnostics. 2025-01-31
Press Mentions
- Mate Pair Sequencing Yields Rich New DataNovember 1st, 2019
- Genomic Variant That Increases Risk of Brain Tumors DiscoveredAugust 26th, 2012
Grant Support
- CytogeneticsNational Cancer Institute2009–2012
- Identification Of 9p And 20q Germline Alterations In Glioblastoma PathogenesisNational Institute Of Neurological Disorders And Stroke2009–2010
- Core--CytogeneticsNational Cancer Institute2004–2008
- Molecular Markers Of Glioma Initiation And ProgressionNational Cancer Institute2004
- Molecular Markers Of Glioma Initiation And ProgressionNational Cancer Institute2001–2003
- Core--Study Design And Data AnalysisNational Cancer Institute2001–2002
- Core--Molecular MarkersNational Cancer Institute2001–2002
- Biologic And Clinical Studies Of 19q And 1p In GliomasNational Cancer Institute2001–2002
- 8q24 Region Associated With Prostate Cancer ProgressionNational Cancer Institute2001–2002
- Core--CytogeneticsNational Cancer Institute1999–2002
- Genetic And Biologic Studies Of 1p And 19q In GliomasNational Cancer Institute2000–2001
- Molecular Pathology Of GliomasNational Cancer Institute1994–2000
- Cancer GeneticsNational Cancer Institute1993–1999
- Core--Cytogenetics ResearchNational Cancer Institute1993–1998
- Investigation Of The Molecular Pathology Of GliomasNational Cancer Institute1989–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: